Showing results (151-160 of 200) with videos related to

Sort By:
Pageof 20
Immunity|December 1, 1996
Corepression of RelA and c-rel inhibits immunoglobulin kappa gene transcription and rearrangement in precursor B lymphocytesD C Scherer, J A Brockman, H H Bendall, et al.
Revue Neurologique|November 9, 2010
[Hereditary optic atrophies]C Scherer, V Procaccio, M Ferre, et al.
Molecular and Cellular Biology|May 1, 1996
Inactivation of IkappaBbeta by the tax protein of human T-cell leukemia virus type 1: a potential mechanism for constitutive induction of NF-kappaBT A McKinsey, J A Brockman, D C Scherer, et al.
The Lancet. Neurology|August 16, 2014
Safety and efficacy of LY2951742, a monoclonal antibody to calcitonin gene-related peptide, for the prevention of migraine: a phase 2, randomised, double-blind, placebo-controlled studyDavid W Dodick, Peter J Goadsby, Egilius L H Spierings, et al.
Plos Biology|April 22, 2016
"One Health" or Three? Publication Silos Among the One Health DisciplinesKezia R Manlove, Josephine G Walker, Meggan E Craft, et al.
BMC Infectious Diseases|January 2, 2010
Cost-effectiveness analysis of PCR for the rapid diagnosis of pulmonary tuberculosisLuciene C Scherer, Rosa D Sperhacke, Antonio Ruffino-Netto, et al.
Scientific Reports|October 18, 2017
Environmental and behavioral changes may influence the exposure of an Arctic apex predator to pathogens and contaminantsTodd C Atwood, Colleen Duncan, Kelly A Patyk, et al.
Epidemiology and Infection|August 1, 2014
Evaluating vaccination strategies to control foot-and-mouth disease: a model comparison studyS E Roche, M G Garner, R L Sanson, et al.
Clinical Endocrinology|April 1, 1996
Risk factors for secondary hyperparathyroidism in a nursing home populationM S Stein, S C Scherer, S L Walton, et al.
European Journal of Neurology|October 19, 2007
Cognitive changes in asymptomatic carriers of the Huntington disease mutation geneC Verny, P Allain, A Prudean, et al.
Pageof 20